SIDE EFFECTS The most common adverse events reported in clinical trials for Cagrilintide, both as monotherapy and as CagriSema, are primarily gastrointestinal (GI) in nature, typically classified as mild to moderate in severity
During chemotherapy, for example, the substances cell-protective effects may interfere with the efficacy of certain cancer medications
It is only used for injections such as intravenous, intramuscular and subcutaneous
For patients with absorption issues from bariatric surgery, IBD, celiac, or chronic dehydration, the difference is not subtle
doi: 10.1111/sji.12998 14
Pete Pastides GBR Age Group Triathlete FAQs What is Glutathione, and why is it important